These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 26646995)

  • 1. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
    Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
    Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.
    Youssef G; Leung E; Mylonas I; Nery P; Williams K; Wisenberg G; Gulenchyn KY; Dekemp RA; Dasilva J; Birnie D; Wells GA; Beanlands RS
    J Nucl Med; 2012 Feb; 53(2):241-8. PubMed ID: 22228794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the diagnostic performance of [
    Shen Y; Yang Y
    Clin Imaging; 2024 Sep; 113():110248. PubMed ID: 39096887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of quantitative assessment of cardiac
    Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
    Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of
    Kim SJ; Lee SW
    Br J Radiol; 2018 Jan; 91(1081):20170519. PubMed ID: 29099613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Xiao Y; Wang L; Jiang X; She W; He L; Hu G
    Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging.
    Scholtens AM; Verberne HJ; Budde RP; Lam MG
    J Nucl Med; 2016 Apr; 57(4):568-73. PubMed ID: 26659348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Masuda A; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Hirata K; Nishimura M; Tamaki N
    J Nucl Cardiol; 2016 Apr; 23(2):244-52. PubMed ID: 26243179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
    Ruilong Z; Daohai X; Li G; Xiaohong W; Chunjie W; Lei T
    Nucl Med Commun; 2017 Jan; 38(1):67-75. PubMed ID: 27741214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Aitken M; Chan MV; Urzua Fresno C; Farrell A; Islam N; McInnes MDF; Iwanochko M; Balter M; Moayedi Y; Thavendiranathan P; Metser U; Veit-Haibach P; Hanneman K
    Radiology; 2022 Sep; 304(3):566-579. PubMed ID: 35579526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of
    Kim SJ; Lee SW; Pak K; Kim IJ; Kim K
    Br J Radiol; 2018 Jun; 91(1086):20170520. PubMed ID: 29327944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.